Cyclophosphamide Drug Interaction Study In Cancer Patients
Status:
Terminated
Trial end date:
2009-10-14
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the potential pharmacokinetic interaction between oral
GW679769 and IV (intravenous) cyclophosphamide when administered to cancer patients.